Poseida Therapeutics, Inc. Annual Operating Lease, Payments in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Poseida Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2020 to 2023.
  • Poseida Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $1.5M, a 11.8% decline year-over-year.
  • Poseida Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $6.3M, a 20.3% decline from 2022.
  • Poseida Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $7.9M, a 29.5% increase from 2021.
  • Poseida Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $6.1M, a 27.1% increase from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6.3M -$1.6M -20.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $7.9M +$1.8M +29.5% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-09
2021 $6.1M +$1.3M +27.1% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-10
2020 $4.8M Jan 1, 2020 Dec 31, 2020 10-K 2021-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.